| Risk factors for misuse of prescribed opioids: a systematic review and meta-analysis A Cragg, JP Hau, SA Woo, SA Kitchen, C Liu, MM Doyle-Waters, CM Hohl Annals of emergency medicine 74 (5), 634-646, 2019 | 150 | 2019 |
| Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study R Grewal, SA Kitchen, L Nguyen, SA Buchan, SE Wilson, AP Costa, ... Bmj 378, 2022 | 144 | 2022 |
| Measuring the burden of opioid-related mortality in Ontario, Canada, during the COVID-19 pandemic T Gomes, SA Kitchen, R Murray JAMA Network Open 4 (5), e2112865-e2112865, 2021 | 75 | 2021 |
| Association between increased dispensing of opioid agonist therapy take-home doses and opioid overdose and treatment interruption and discontinuation T Gomes, TJ Campbell, SA Kitchen, R Garg, N Bozinoff, S Men, ... Jama 327 (9), 846-855, 2022 | 63 | 2022 |
| Clinical outcomes and health care costs among people entering a safer opioid supply program in Ontario T Gomes, G Kolla, D McCormack, A Sereda, S Kitchen, T Antoniou CMAJ 194 (36), E1233-E1242, 2022 | 43 | 2022 |
| Trends in hospitalizations for serious infections among people with opioid use disorder in Ontario, Canada T Gomes, SA Kitchen, L Tailor, S Men, R Murray, AM Bayoumi, ... Journal of Addiction Medicine 16 (4), 433-439, 2022 | 29 | 2022 |
| Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis SA Kitchen, TJ Campbell, S Men, N Bozinoff, M Tadrous, T Antoniou, ... International Journal of Drug Policy 103, 103644, 2022 | 26 | 2022 |
| The effects of COVID‐19 on the dispensing rates of antidepressants and benzodiazepines in Canada S Uthayakumar, M Tadrous, SN Vigod, SA Kitchen, T Gomes Depression and Anxiety 39 (2), 156-162, 2022 | 26 | 2022 |
| Preliminary patterns in circumstances surrounding opioid-related deaths in Ontario during the COVID-19 pandemic T Gomes Ontario Drug Policy Research Network, 2020 | 18 | 2020 |
| Vaccine effectiveness of BNT162b2 against delta and omicron variants in adolescents SA Buchan, L Nguyen, SE Wilson, SA Kitchen, JC Kwong Pediatrics 150 (3), e2022057634, 2022 | 17 | 2022 |
| Effectiveness of a fourth dose of COVID-19 vaccine among long-term care residents in Ontario, Canada: test-negative design study R Grewal, SA Kitchen, L Nguyen, SA Buchan, SE Wilson, AP Costa, ... medRxiv, 2022.04. 15.22273846, 2022 | 16 | 2022 |
| Emergency department-based medication review on outpatient health services utilization: interrupted time series SA Kitchen, K McGrail, ME Wickham, MR Law, CM Hohl BMC Health Services Research 20, 1-10, 2020 | 14 | 2020 |
| Trends and outcomes of serious complications associated with non-fatal opioid overdoses in Ontario, Canada SA Kitchen, D McCormack, D Werb, A Caudarella, D Martins, FI Matheson, ... Drug and alcohol dependence 225, 108830, 2021 | 13 | 2021 |
| Impact of the COVID-19 pandemic on the prevalence of opioid agonist therapy discontinuation in Ontario, Canada: A population-based time series analysis R Garg, SA Kitchen, S Men, TJ Campbell, N Bozinoff, M Tadrous, ... Drug and Alcohol Dependence 236, 109459, 2022 | 12 | 2022 |
| Patterns of medication and healthcare use among people who died of an opioid-related toxicity during the COVID-19 pandemic in Ontario T Gomes, R Murray, G Kolla, P Leece, S Kitchen, T Campbell, J Besharah, ... Toronto, ON, 2022 | 12 | 2022 |
| Projected impact of biosimilar substitution policies on drug use and costs in Ontario, Canada: a cross-sectional time series analysis T Gomes, D McCormack, SA Kitchen, JM Paterson, MM Mamdani, ... Canadian Medical Association Open Access Journal 9 (4), E1055-E1062, 2021 | 8 | 2021 |
| Trends in rates of opioid agonist treatment and opioid-related deaths for youths in Ontario, Canada, 2013-2021 T Rosic, G Kolla, P Leece, S Kitchen, T Gomes JAMA Network Open 6 (7), e2321947-e2321947, 2023 | 7 | 2023 |
| Lives lost to opioid toxicity among Ontarians who worked in the construction industry T Gomes, A Iacono, G Kolla, E Nunez, P Leece, T Wang, T Campbell, ... On behalf of: The Ontario Drug Policy Research Network, The Office of the …, 2022 | 5 | 2022 |
| Vaccine effectiveness of BNT162b2 against Omicron and Delta outcomes in adolescents SA Buchan, L Nguyen, SE Wilson, SA Kitchen, JC Kwong medRxiv, 2022.04. 07.22273319, 2022 | 5 | 2022 |
| Effect of listing strategies on utilization of antitumor necrosis factor biologics infliximab and etanercept: a cross-sectional analysis from Ontario, Canada J Fenna, D McCormack, S Kitchen, D Martins, T Gomes, M Tadrous Journal of Managed Care & Specialty Pharmacy 27 (4), 444-452, 2021 | 5 | 2021 |
